AIDE: A Randomized Cross-over Trial Evaluating Automated Insulin Delivery Technologies on Hypoglycemia and Quality of Life in Elderly Adults with Type 1 Diabetes (Automated Insulin Delivery in Elderly with Type 1 Diabetes [AIDE t1D])
Associated ConditionsDiabetes-Care Delivery
The purpose of this study is to see if features of an automated insulin delivery system (study system) can reduce low blood sugar (hypoglycemia) in older adults with type 1 diabetes. We expect up to 150 people will take part in this study at 3 to 5 sites in the United States for about 14 months.
This study is currently enrolling.